This challenge funds the creation and dissemination of innovative RNA-targeting technologies to develop precision RNA-targeted therapies. It focuses on diseases caused by protein targets that are difficult to drug or diseases rooted in RNA dysfunction with no current cure. The initiative aims to advance therapeutic options by targeting RNA upstream of protein expression.
Eligibility criteria are not specified for this funding opportunity.
